BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11431772)

  • 21. Matrix metalloproteinases and their inhibitors in human pituitary tumors.
    Beaulieu E; Kachra Z; Mousseau N; Delbecchi L; Hardy J; Béliveau R
    Neurosurgery; 1999 Dec; 45(6):1432-40; discussion 1440-1. PubMed ID: 10598711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
    Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
    J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.
    Katayama N; Murao S; Ajiki T; Kitazawa S; Onoyama H; Kuroda Y; Maeda S
    Int J Mol Med; 2000 Nov; 6(5):539-42. PubMed ID: 11029520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
    Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
    Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
    Shim KN; Jung SA; Joo YH; Yoo K
    J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
    Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
    Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
    Ara T; Fukuzawa M; Kusafuka T; Komoto Y; Oue T; Inoue M; Okada A
    J Pediatr Surg; 1998 Aug; 33(8):1272-8. PubMed ID: 9722003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families.
    He XX; Shi LL; Qiu MJ; Li QT; Wang MM; Xiong ZF; Yang SL
    Biochem Biophys Res Commun; 2018 Oct; 504(4):878-884. PubMed ID: 30219235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
    Li HJ; Chen YX; Wang Q; Zhang YG
    Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.